verified SJR 1,588 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · John Wiley and Sons Inc

workspace_premium Q1 — Urology lock_open Open Access

BJU International

BJU International is a journal indexed in SJR in Urology with an H index of 174. It has a price of 2395 €. It has an SJR impact factor of 1,588 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,588.

BJU International focuses its scope in these topics and keywords: prostate, cancer, patients, study, radical, results, management, screening, cell, bladder, ...

ISSN: 1464-4096

Publisher: John Wiley and Sons Inc

Category: Urology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,588 Q1

H-index 174

Acceptance rate pie_chart

21% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.395 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,588

H-index

174

Docs (year)

341

Docs 3y

729

Total refs

7781

Cites 3y

2500

Citable 3y

539

Cites/Doc 2y

3.42

Ref/Doc

22.82

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996-2001)

Watchful waiting in prostate cancer: review and policy proposals

Erectile dysfunction after radical prostatectomy

ErbB receptors: possible therapeutic targets in prostate cancer?

Endourological management of upper tract transitional cell carcinoma

Editorial comment

Does delaying pyeloplasty affect renal function in children with prenatal diagnosis of pelvi-ureteric junction obstruction?

Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma

Cytopathological expression of different types of urothelial carcinoma in situ in urinary bladder washings

Current status of linkage studies in hereditary prostate cancer

Correspondence

Comparison of the effects of novel antimuscarinic drugs on human detrusor smooth muscle

SHOW MORE ARTICLES

Comparison of percutaneous with transurethral cystolithotripsy in patients with large prostates and large vesical calculi undergoing simultaneous transurethral prostatectomy

A comparison of palpable and impalpable cryptorchid testes using CD-99 immunohistochemistry

Brachytherapy: the surgeon's perspective

Bladder cancer in nonagenarians: a multicentre study of 123 patients

Biodegradable urethral stents

Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy

Are new-generation flexible ureteroscopes better than their predecessors?

Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury

Androgen-independent prostate cancer: a growth area?

A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence

A preoperative clinical prognostic model for non-metastatic renal cell carcinoma

A novel pyrrole derivative, NS-8, suppresses the rat micturition reflex by inhibiting afferent pelvic nerve activity

FAQs

BJU International has an SJR of 1,588 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2395 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for BJU International is 21%.

BJU International

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of BJU International?

What is the APC / publication cost?

What is the acceptance rate?